We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Computerized Drug Warning Alerts Remain Largely Ignored

By HospiMedica International staff writers
Posted on 19 Apr 2012
Print article
A new study finds that 96% of computerized drug warning alerts generated in hospitals are overridden out of hand.

Researchers at the Johns Hopkins Bayview Medical Center (Baltimore, MD, USA) examined data from the 410-bed academic medical center to clarify the factors associated with accepting or overriding a warning from the hospital computerized provider order entry (CPOE) system, developed to generate warnings when there is the possibility of allergy, adverse events, interactions, and duplications, with the intent of increasing inpatient safety. To do so, they identified 6,646 patients - mean age 57, 44% male, with a mean length of hospital stay of four days. When differentiated, 45% were on medical wards, 29% in psychiatric departments, 28% on surgical wards, , and small numbers in other departments such as obstetrics and gynecology.

The researchers found that for the patients whose medication orders generated at least a single warning, the median range of medications per patient was four. The reasons for the warnings were duplications in 47%, potential interactions in 47%, allergies in 6%, and only 0.1% for potential adverse reactions. One-quarter of the warnings were for parenteral medications, and 13% were on the list of high-alert medications. While only 4% of the warnings for oral medications were accepted, warnings for parenteral medications were accepted twice as often, at 8%. The study was presented at the Society of Hospital Medicine (SHM) annual meeting, held during April 2012 in San Diego (CA, USA).

“The least common warnings were those that were most frequently accepted, with the average accepted warnings for drug interactions and allergy being 37% and 10%, respectively,” said lead author and study presenter Amy Knight, MD. “The problem with these computerized warning systems is that providers develop 'alert fatigue' and end up overriding many potentially important warnings.”

“Developers of these computerized provider systems need to revise their programs to more clearly differentiate between types of warnings and, in particular, to distinguish the warnings that are most likely to have severe consequences,” concluded Dr. Knight.

Related Links:

Johns Hopkins Bayview Medical Center


Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Flocked Fiber Swabs
Puritan® patented HydraFlock®
New
Intensive Phototherapy Unit
BC 250 LCD
New
Anesthesia System
WATO EX-65

Print article

Channels

Critical Care

view channel
Image: The microfluidic chip analyzes the chemotactic migration behaviors of neutrophils in sepsis patients (Talanta, 2024; DOI: 10.1016/j.talanta.2024.126801)

Microfluidic Chip Method to Improve Sepsis Diagnosis, Progression Evaluation and Prognosis Monitoring

Sepsis, a severe and life-threatening condition, results from an uncontrolled immune response that can lead to multi-organ failure. Given its high mortality rate and the limitations of current diagnostic... Read more

Surgical Techniques

view channel
Image: Illustration of how the razor-sharp flakes of graphene line up together on a surface and can kill bacteria without harming healthy human cells (Photo courtesy of Yen Sandqvist)

Ultra-Thin Graphene-Based Coating Material Paves Way for Bacteria-Killing Medical Devices

Healthcare-associated infections are a significant global issue, leading to immense suffering, increased healthcare costs, and a greater risk of antibiotic resistance. These infections often occur when... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Point of Care

view channel
The Atellica VTLi Patient-side Immunoassay Analyzer, a high-sensitivity troponin I test at the bedside, delivers accurate results in just 8 minutes (Photo courtesy of Siemens Healthineers)

New 8-Minute Blood Test to Diagnose or Rule Out Heart Attack Shortens ED Stay

Emergency department overcrowding is a significant global issue that leads to increased mortality and morbidity, with chest pain being one of the most common reasons for hospital admissions.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.